Samsung, revs growing and bullish call but no one cares cause everyone knows they'll never earn a penny, keep saying how great things are and issue more dilutive stock to keep themselves employed. Come on, someone step up and buy the stock.
traders know Zisk is out there driving stock down. Hopefully he'll be done soon or he puts up block through broker.
Still a lot of stock he can dump
Mr. Zisk may be deemed to be the beneficial owner of 7,851,315 shares of Common Stock, consisting of:
6,029,875 held by him directly, or 7.63% of the outstanding shares of Common Stock;
1,457,117 shares of Common Stock held by the Jennifer Kate Partnership, LP, or 1.84% of the outstanding shares of Common Stock; and
364,323 shares of Common Stock held by the Zisk Family Partnership, LP, or 0.46% of the outstanding shares of Common Stock.
except this horse has two fat jockeys on it that eat all the horse food so our horse is sitting there and wondering where are all the other going?
• Summary: On Tuesday, April 28, Merge Healthcare reported mixed first quarter 2015 results; pro forma revenue of $55.0 million was slightly below the $56.2 million consensus expectation (but up 7.8% year-over-year, the first year-over-year increase in eight quarters), and adjusted EBITDA were $10.5 million, also slightly below the consensus target of $11.8 million (although up 3.0% year-over-year). However, adjusted earnings per share of $0.05 were a penny above the $0.04 consensus target. The mixed quarterly results were overshadowed by two clear positives: organic quarterly bookings growth of 60% and management's guidance that it believes the company will meet or exceed consensus 2015 targets going into the call of $248 million in revenue (including roughly 7% organic growth) and $0.21 in adjusted EPS (up a penny year-over-year, unless accelerated adoption of the new iConnect offering mandates higher investment spend).
• The company also reiterated financial details mentioned on the prior earnings call at the end of February regarding the acquisition of DR Systems, which was announced in conjunction with that call. DR Systems is a privately held San Diego-based company that competed with Merge in the radiology space. Management confirmed its expectation that DR Systems was on pace to deliver $40 million in revenue and $10 million in adjusted EBITDA in 2015 (roughly flat compared with its performance the last couple years) and will contribute similarly on a pro rata basis in the 10 post-acquisition months in 2015 for the combined company . The company believes the acquisition integration has progressed well to date, and the customer feedback on the combined entity has supported the idea that a larger organization will be better equipped to grow alongside clients own growth objectives. The company will continue to support DR Systems' core platform and look to advance all product lines.
will get back there, both Blair and Baird were on call. Baird rates neutral and Blair doesn't officially cover so may get some coverage/upgrades based on good outlook.
just what it says...docs may have to do a dry eye test for patients that are going to have surgery. Reason to install TEAR test system in eye surgeons' office.
Dont think these idiots even talk to mgt. I also knew delay of 10K since they changed to BDO and had the transactions during the qtr. It'll be filed shortly.
"The company needs additional time to complete the financial statements of the Company due to certain events which occurred in the first quarter of 2015"
did offering and sold assets.